Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesPolymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes
Leukemia Research, 06/19/09
Fabiani E et al. - Rhe GSTP1-105Val allele was associated to an increased risk of MDS and to higher probability of overall survival in the low/intermediate-1 IPSS risk group. The GSTP1-Ile105Val polymorphism is likely to influence MDS risk and prognosis.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09
Breast cancer in the elderly: a histological assessment
Histopathology, 10/15/09
Serum calcium levels are elevated among women with untreated postmenopausal breast cancer
Cancer Causes and Control, 11/03/09
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Bortezomib: a new therapeutic option for POEMS syndrome
European Journal of Haematology, 10/13/09
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Prognostic molecular markers in myelodysplastic syndromes
Expert Review of Hematology, 10/22/09
Sponsor
Article Search
Sponsor
Sponsor